You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

abiraterone

( a-bi-RA-te-rone )
Funding:
Exceptional Access Program
  • abiraterone - Metastatic castrate-resistant prostate cancer, with specific criteria
Other Name(s): Zytiga® (Janssen)
Appearance: tablet in various colours and strengths

You might also be interested in